NX Development
Manufacturing · Kentucky, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
870 Corporate Dr Ste 403, Lexington, Ken...Phone Number
(833) 453-6526Website
www.nxdevcorp.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About NX Development
NX Development Corp is a leading life sciences company focused on innovative solutions for brain cancer treatment. Their flagship product, Gleolan, is a real-time imaging agent that assists neurosurgeons in visualizing and removing malignant tissue during surgery for high-grade gliomas. With FDA approval for Gleolan, the company aims to revolutionize fluorescence guided surgery and improve patient outcomes. Committed to advancing diagnostic options, NX Development Corp strives to provide hope and better recovery chances for brain cancer patients.Explore more
NX Development Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NX Development your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if NX Development has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at NX Development
Earning: See what the market has to say on NX Development recently announced quarterly report
Funding: Get notified immidiatlly once NX Development has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
NX Development, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if NX Development had a recent Job posting/layoffs
Check out if NX Development is spiking on competitors!
Product Launch: Get notified when NX Development launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to NX Development
Compare insights from companies similar to NX Development, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NX Development is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NX Development is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NX Development.
NX Development financials insights
Gather financial insights about NX Development, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$700K
NX Development Tech Stack
A closer look at the technologies used by NX Development
NX Development News & Media
Medexus Pharmaceuticals Announces Deal for Gleolan in the United States
Medexus has acquired exclusive rights to commercialize Gleolan in the United States, complementing Medexus’s existing rights to Gleolan in CanadaTJ Stalvey Joins NX Development Corp. (NXDC) as Vice President of Clinical Development and ...
Lexington, KY, April 15, 2021 (GLOBE NEWSWIRE) -- NX Development Corp. (NXDC), a life-sciences company wholly owned by photonamic GmbH & Co. KG.,...NX Development Corp. (NXDC) Launches Gleolan (aminolevulinic acid HCl) Meningioma Phase III Clinical Trial (NXDC-MEN-301)
Lexington, KY, Nov. 17, 2020 (GLOBE NEWSWIRE) -- NX Development Corp (NXDC), a life sciences company wholly owned by photonamic GmbH & Co. KG., today announced the enrollment of the first patient in a Phase III multicenter study of Gleolan to enhance visualization of brain tumors in patients with newlyLexington-Based NX Development Corp (NXDC) Announces Baptist Health Lexington is First Hospital in Kentucky to Use Breakthrough Imaging Agent for Brain Tumor Visualization
Dr. Christian Ramsey first neurosurgeon in state to use Gleolan for enhanced visualization of high-grade gliomas/glioblastoma Dr. Christian Ramsey first neurosurgeon in state to use Gleolan for enhanced visualization of high-grade gliomas/glioblastoma
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NX Development
Sign Up For FreeTo access detailed company insights
NX Development Corp is a leading life sciences company focused on innovative solutions for brain cancer treatment. Their flagship product, Gleolan, is a real-time imaging agent that assists neurosurgeons in visualizing and removing malignant tissue during surgery for high-grade gliomas. With FDA approval for Gleolan, the company aims to revolutioni... Read More
